[go: up one dir, main page]

AU2002359403A1 - METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER - Google Patents

METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER

Info

Publication number
AU2002359403A1
AU2002359403A1 AU2002359403A AU2002359403A AU2002359403A1 AU 2002359403 A1 AU2002359403 A1 AU 2002359403A1 AU 2002359403 A AU2002359403 A AU 2002359403A AU 2002359403 A AU2002359403 A AU 2002359403A AU 2002359403 A1 AU2002359403 A1 AU 2002359403A1
Authority
AU
Australia
Prior art keywords
modulation
regulation
compositions
methods
gene expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002359403A
Other versions
AU2002359403A8 (en
Inventor
Ching-Yi Chen
Michael Karin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of AU2002359403A8 publication Critical patent/AU2002359403A8/en
Publication of AU2002359403A1 publication Critical patent/AU2002359403A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002359403A 2001-11-15 2002-11-14 METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER Abandoned AU2002359403A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33471201P 2001-11-15 2001-11-15
US60/334,712 2001-11-15
PCT/US2002/036665 WO2003044166A2 (en) 2001-11-15 2002-11-14 METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER

Publications (2)

Publication Number Publication Date
AU2002359403A8 AU2002359403A8 (en) 2003-06-10
AU2002359403A1 true AU2002359403A1 (en) 2003-06-10

Family

ID=23308474

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002359403A Abandoned AU2002359403A1 (en) 2001-11-15 2002-11-14 METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER

Country Status (2)

Country Link
AU (1) AU2002359403A1 (en)
WO (1) WO2003044166A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9085778B2 (en) 2006-05-03 2015-07-21 VL27, Inc. Exosome transfer of nucleic acids to cells
CN103237901B (en) 2010-03-01 2016-08-03 卡里斯生命科学瑞士控股有限责任公司 For treating the biomarker of diagnosis
CA2795776A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers for disease
MX2015014666A (en) 2013-04-17 2016-03-01 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases.
WO2015048844A1 (en) * 2013-10-02 2015-04-09 Xosoma Pty Ltd A method of producing exosomes
CA2988585A1 (en) 2015-06-10 2016-12-15 Raghu Kalluri Use of exosomes for the treatment of disease
CN108715830B (en) * 2018-05-04 2019-08-06 中南大学湘雅医院 Extraction method and application of urine-derived stem cell exosomes
CN120384146A (en) * 2023-09-18 2025-07-29 河南农业大学 Maize ZmRRP45B gene mutation SNP marker, dCAPS primers and their applications

Also Published As

Publication number Publication date
WO2003044166A2 (en) 2003-05-30
AU2002359403A8 (en) 2003-06-10
WO2003044166A3 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
AU2002253836A1 (en) Aptamer-mediated regulation of gene expression
AU2002357759A1 (en) Manipulation of cytokine levels using cd83 gene products
AU2002332020A1 (en) Compositions for oral gene therapy and methods of using same
AU2002251266A1 (en) Inhibitors of akt activity
EP1177277A4 (en) Compositions and methods for the modification of gene transcription
AU2003288686A1 (en) Compositions and systems for the regulation of genes
IL157694A0 (en) Method of determining dihydropyrimidine dehydrogenase gene expression
AU1723001A (en) Methods and means for regulation of gene expression
AU2002359403A1 (en) METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER
WO2002077885A8 (en) Distribution system and method of operation thereof
AU2003257966A1 (en) Antisense modulation of lar expression
AU2001269077A1 (en) Methods and means for regulation of gene expression
AU2002219992A1 (en) Targeted regulation of gene expression
AU2841500A (en) Dehiscence gene and methods for regulating dehiscence
AU2002325305A1 (en) Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression
AU3902799A (en) Compositions and methods for genetic transformation of pineapple
AU5645599A (en) Regulation of gene expression through manipulation of mrna splicing and its uses
AU2001264937A1 (en) Haplotypes of the agtrl1 gene
AU2002342417A1 (en) Inhibitors of dna methyltransferase isoforms
AU2271701A (en) Inhibitors of interleukin 5 gene expression
AU2002354255A1 (en) Mtehod of analyzing gene expression
AU2002343607A1 (en) Enzymatic manipulation of metal particle-bound dna
AU2002317373A1 (en) Control of gene expression
AU2003257285A1 (en) Inhibitors of rna dependent rna polymerase and uses thereof
AU2002328226A1 (en) Modulation of retinoic acid receptor gene expression and therapeutic uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase